Several studies have assessed the potentially increased rate and the management of osteoporotic and fragility fractures during the COVID-19 pandemic.
The American College of Rheumatology developed guidelines for the management of gout, including use of urate-lowering therapy, flare treatment, and lifestyle and medication recommendations.
Experts have advised the evaluation of spondyloarthritis in patients with inflammatory bowel disease.
In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Researchers found that drugs used to treat rheumatoid arthritis have been associated with varicella zoster activation.
Weight loss in patients who are overweight or obese may improve symptoms through pathologic mechanisms in addition to reduction of joint burden.
Given the substantial overlap with RA, emerging theories suggest that undifferentiated arthritis represents a unique window of opportunity to intervene in the pathology of RA before it becomes established.
Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.
Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.
Quality of life measurements capture unique information about systemic lupus erythematosus that are not included in disease activity or damage evaluations.
